Product Images Magnesium Sulfate

This appears to be a list of various substances including alcohol, heavy metals, alkali carbonates and bicarbonates, hydrocortisone sodium succinate, alkali hydroxides, phosphates, arsenates, polymyxin B sulfate, barium, procaine hydrochloride, calcium, salicylates, clindamycin phosphate, strontium, and tartrates. It is not clear what this is referring to specifically or why the list is important.*

This is a table containing information about different types of Magnesium Sulfate fill products with their corresponding NDC codes, volume, and concentration levels. The table includes four different products, each with a unique NDC code and a volume of either 2mL or 10mL. The concentration levels for all products are the same at 500 mg/mL, and the magnesium sulfate is in heptahydrate form.*

This is a description of Magnesium Sulfate 50% Injection, USP. It is available in a 2ml single dose vial and can be used through intramuscular injection or intravenous use, after being diluted. It is sterile and preservative-free. Unused portions should be discarded. Each milliliter contains magnesium sulfate, heptahydrate, and water for injection with less than 300mcg/L of aluminum. The pH adjustment is done with sulfuric acid and/or sodium hydroxide. It should be stored at a controlled room temperature between 69-77°F. This product is manufactured by Fresenius Kabi and the packaging is done by Henry Schein, Inc. It is only for prescription use with RX ONLY label.*

This is a list of references related to the effects of prolonged maternal magnesium administration and the associated bone metabolism in neonates. The studies mentioned here include investigations into the adverse maternal and neonatal outcomes of magnesium sulfate tocolysis and its effects on neonatal calcium metabolism and bone mineral content. Some of the studies report cases of skeletal demineralization, fractures, and congenital rickets in newborns whose mothers received magnesium sulphate for tocolysis of premature labor.*